CD44 isoform expression in the diffuse neuroendocrine system. II. Benign and malignant tumors

Histochemistry and Cell Biology

Volumn 106, Issue 6, 1996, Pages 551-562

  Komminoth, Paul ^a   Seelentag, Walter K F ^a   Saremaslani, Parvin ^a   Heitz, Philipp U ^a   Roth, Jürgen ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ADRENAL GLAND; ADRENAL MEDULLA; ARTICLE; CONTROLLED STUDY; GASTROINTESTINAL TRACT; HUMAN; HUMAN TISSUE; HYPOPHYSIS; IMMUNOHISTOCHEMISTRY; LUNG; NEUROENDOCRINE TUMOR; PANCREAS; PARATHYROID GLAND; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; THYROID GLAND;

EID: 0030444393     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02473270     Document Type: Article

References (52)

1. Altman DG (1995) Practical statistics for medical research. Chapman and Hall, London
2. Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I (1996) Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol 132:1199-1208
3. Calnek D, Quaroni A (1993) Differential localization by in situ hybridization of distinct keratin mRNA species during intestinal epithelial cell development and differentiation. Differentiation 53:95-104
4. Capella C, Heitz PU, Hofler H, Solcia E, Kloppel G (1995) Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 425:547-560
5. Chaudhry A, Gobl A, Eriksson B, Skogseid B, Oberg K (1994) Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors. Cancer Res 54:981-986
6. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
7. Christiansen H, Sabin K, Berthold F, Hero B, Terpe HJ, Lampert F (1995) Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in neuroblastoma. Eur J Cancer 31A:541-544
8. Combaret V, Lasset C, Frappaz D, Bouvier R, Thiesse P, Rebillard AC, Philip T, Favrot MC (1995) Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors. Eur J Cancer 31A:545-549
9. Combaret V, Gross N, Lasset C, Frappaz D, Peruisseau G, Philip T, Beck D, Favrot MC (1996) Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas. J Clin Oncol 14:25-34
10. Coppola D, Clarke M, Landreneau R, Weyant RJ, Cooper D, Yousem SA (1996) bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung. Modern Pathol 9:484-490
11. DeLellis R, Dayal Y (1992) Neuroendocrine system. In: Sternberg SS (eds) Histology for pathologists. Raven Press, New York, pp 347-362
12. East JA, Mitchell SD, Hart IR (1993) Expression and function of the CD44 glycoprotein in melanoma cell lines. Melanoma Res 3:341-346
13. Faassen AE, Schrager JA, Klein DJ, Oegema TR, Couchman JR, McCarthy JB (1992) A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol 116:521-531
14. Figge J, del Rosario AD, Gerasimov G, Dedov I, Bronstein M, Troshina K, Alexandrova G, Kallakury BV, Bui HX, Bratslavsky G et al (1994) Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma. Exp Mol Pathol 61: 203-211
15. Friedrichs K, Franke F, Lisboa BW, Kügler G, Gille I, Terpe HJ, Hölzel F, Maass H, Günthert U (1995) CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res 55:5424-5433
16. Ghaffari S, Dougherty GJ, Lansdorp PM, Eaves AC, Eaves CJ (1995) Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood 86:2976-2985
17. Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D, Beck D (1994) CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res 54:4238-4242
18. Günthert U, Stauder R, Mayer B, Terpe HJ, Finke L, Friedrichs K (1995) Are CD44 variant isoforms involved in human tumour progression? Cancer Surv 24:19-12
19. Günthert U (1996) CD44 in malignant disorders. Curr Top Microbiol Immunol 213:271-285
20. Guo Y, Ma J, Wang J, Che X, Narula J, Bigby M, Wu M, Sy MS (1994) Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res 54:1561-1565 [erratum 54:2284]
21. Herrlich P, Rudy W, Hofmann M, Arch R, Zöller M, Zawadzki V, Tölg C, Hekele A, Koopman G, Pals ST, Heider KH, Sleeman J, Ponta H (1993a) CD44 and splice variants of CD44 in normal differentiation and tumor progression. In: Hemler ME, Mihich E (eds) Cell adhesion molecules. Plenum Press, New York, pp 265-288
22. Herrlich P, Zöller M, Pals ST, Ponta H (1993b) CD44 splice variants: metastases meet lymphocytes. Immunol Today 14:395-399
23. Hong RL, Pu YS, Chu JS, Lee WJ, Chen YC, Wu CW (1995) Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma. Cancer Lett 89:81-87
24. Khandjian EW (1987) Optimised hybridization of DNA blotted and fixed to nitrocellulose and nylon membranes. Biotechniques 5:165-167
25. Komminoth P, Roth J, Lackie PM, Bitter Suermann D, Heitz PU (1991) Polysialic acid of the neural cell adhesion molecule distinguishes small cell lung carcinoma from carcinoids. Am J Pathol 139:297-304
26. Komminoth P, Roth J, Saremaslani P, Matias Guiu X, Wolfe HJ, Heitz PU (1994) Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions. Am J Surg Pathol 18:399-411
27. Komminoth P, Roth J, Schröder S, Saremaslani P, Heitz PU (1995) Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors. Lab Invest 72:424-431
28. Le Douarin NM (1982) The neural crest. Cambridge University Press, Cambridge, UK
29. Le Douarin NM (1988) On the origin of pancreatic endocrine cells. Cell 53:169-171
30. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U (1994) Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124:71-82
31. Manten Horst E, Danen EH, Smit L, Snoek M, Le Poole IC, van Muijen GN, Pals ST, Ruiter DJ (1995) Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. Int J Cancer 64:182-188
32. Matsumura Y, Tarin D (1992) Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340:1053-1058
33. Moll R (1993) Cytokeratins as markers of differentiation. Expression profiles in epithelia and epithelial tumors. Veroff Pathol 142:1-197
34. Moll R, Zimbelmann R, Goldschmidt MD, Keith M, Laufer J, Kasper M, Koch PJ, Franke WW (1993) The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation 53:75-93
35. Ponta H, Sleeman J, Dall P, Moll J, Sherman L, Herrlich P (1994) CD44 isoforms in metastatic cancer. Invasion Metastasis 14:82-86
36. Penno MB, August JT, Baylin SB, Mabry M, Linnoila RI, Lee VS, Croteau D, Yang XL, Rosada C (1994) Expression of CD44 in human lung tumors. Cancer Res 54: 1381-1387
37. Ristamäki R, Joensuu H, Jalkanen S (1996) Does soluble CD44 reflect the clinical behaviour of human cancer? Curr Top Microbiol Immunol 213:155-166
38. Roth J, Taatjes DJ, Wagner P, Weisgerber C, Heitz PU, Goridis C, Bitter-Suermann D (1988) Reexpression of poly(sialic acid) units of the neural cell adhesion molecule in Wilms tumor. Proc Natl Acad Sci USA 85:2999-3003
39. Roth J, Zuber C, Komminoth P, Scheidegger EP, Warhol MJ, Bitter-Suermann D, Heitz PU (1993) Expression of polysialic acid in human tumors and its significance for tumor growth. In: Roth J, Rutishauser U, Troy FA (eds) Polysialic acid: from microbes to man. Birkhäuser, Basel, pp 335-348
40. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, New York
41. Seelentag WKF, Böni R, Günthert U, Futo E, Burg G, Heitz PU, Roth J (1996a) Expression of CD44 isoforms and β1,6-branched oligosaccharides in human malignant melanoma is correlated with tumor progression but not with metastatic potential. J Cutan Pathol (in press)
42. Seelentag WKF, Günthert U, Saremaslani P, Futo E, Pfaltz M, Heitz PU, Roth J (1996b) CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but downregulated during proliferation and tumor dedifferentiation. Int J Cancer 69:218-224
43. Seelentag WKF, Komminoth P, Saremaslami P, Günthert U, Heitz PU, Roth J (1996c) CD44 isoform expression in the diffuse neuroendocrine syslem: I. Normal cells and hyperplasia. Histochem Cell Biol 106:543-550
44. Sherman L, Sleeman J, Herrlich P, Ponta H (1994) Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol 6:726-733
45. Sherman L, Sleeman J, Dall P, Pals ST, Ponta H, Herrlich P (1996) The CD44 proteins in embryonic development and in cancer. Curr Top Microbiol Immunol 213:249-269
46. Shtivelman E, Bishop JM (1991) Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol 11:5446-5453
47. Stauder R, Eisterer W, Thaler J, Günthert U (1995) CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood 85:2885-2899
48. Sy MS, Liu D, Schiavone R, Ma J, Miori H, Guo Y (1996) Interactions between CD44 and hyaluronic acid: their role in tumor growth and metastasis. Curr Top Microbiol Immunol 213:129-153
49. Tanabe KK, Saya H (1994) The CD44 adhesion molecule and metastasis. Crit Rev Oncol 5:201-212
50. Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB Jr, Nieman L, Chrousos G, Pass H, Doppman J (1991) Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 15:529-553
51. West DC, Sattar A, Kumar S (1985) Angiogenesis induced by the degradation products of hyaluronic acid. Science 228:1324-1326
52. Zöller M, Herrlich P, Ponta H (1994) Metastatic tumor cells mimic lymphocytes. Pathol Biol 42:31-32